pharma news today glp-1 today obesity drugs The next phase of the drug race The GLP-1 Access Gap: Mapping – pharma news today obesity drug

Bath application of GLP-1 induces a depolarization in most hippocampal neurons and a hyperpolarization in a few neurons ( in vitro electrophysiological recordings further demonstrated that exendin-4 elicits an early fast excitatory response dose-dependently (Hsu et al., 2015, 2018)

Why DTC GLP-1 Platforms Are Struggling Not all virtual prescribers are DTC. Platforms like Calibrate, Season, and even Noom Med offer coaching and lab integration, gesturing towards outcomes infrastructure

- ]

Our commitment to science-forward formulations means we never cut corners on sourcing or delivery technology

Photos are useful for anything with a visual component

doi: 10.1038/s41598-019-44591-8 124 Novo Nordisk A/S